Swiss drugmaker Novartis is reviewing its business units that do not have global scale and critical mass, its chief executive said on Tuesday.
"It's important that each of our businesses have global scale and critical mass," Joseph Jimenez told reporters on a conference call.
Help employers find you! Check out all the jobs and post your resume.
